首页 | 本学科首页   官方微博 | 高级检索  
     


Cytologic and histologic samples from patients infected by the novel coronavirus 2019 SARS-CoV-2: An Italian institutional experience focusing on biosafety procedures
Authors:Esther Diana Rossi MD  PhD   MIAC  Guido Fadda MD  Antonino Mule MD  Gian Franco Zannoni MD  Guido Rindi MD
Affiliation:1. Unit of Anatomic Pathology, Agostino Gemelli University Policlinic Foundation, IRCCS, Rome, Italy;2. Unit of Anatomic Pathology, Agostino Gemelli University Policlinic Foundation, IRCCS, Rome, Italy

Anatomic Pathology Section, Department of Life Sciences and Public Health, Catholic University of the Sacred Heart, Rome, Italy

Abstract:The 2019 coronavirus pandemic, which started in Wuhan, China, spread around the globe with dramatic and lethal effects. From the initial Chinese epicenter, the European diaspora taxed the resources of several countries and especially those of Italy, which was forced into a complete social and economic shutdown. Infection by droplets contaminating hands and surfaces represents the main vehicle of diffusion of the virus. The common and strong efforts to contain the pandemic have relevant effects on the management of samples from histopathology laboratories. The current commentary reports and focuses on the protocols and guidelines in use at a large tertiary Italian hospital that accordingly are proposed for adoption in Italian laboratories as a potential model for national guidelines for the coronavirus emergency.
Keywords:biosafety guidelines  coronavirus  cytology  fine-needle aspiration  histology  personalized medicine
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号